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Genome instability is a hallmark of cancer. ATP-dependent chromatin 34 
remodelers are frequently altered in cancer. We have recently reported that the 35 
SWItch/Sucrose Non-Fermentable (SWI/SNF) complex protects the genome by limiting 36 
R-loop-mediated genome instability, mainly that caused by transcription-replication 37 
conflicts. Here we discuss the significance and biomedical applications of this finding.  38 
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AUTHOR’S VIEW 79 
In addition to the transcription machinery, non-B DNA structures generated by 80 
transcription may pose an obstacle to replication fork (RF) progression. Co-81 
transcriptional R-loops, three-stranded nucleic acid structures composed of a DNA-82 
RNA hybrid plus a displaced single strand DNA (ssDNA), may occur naturally to serve 83 
a physiological role but its unscheduled formation have been shown to menace 84 
genome integrity (1). Avoidance of such situations is achieved thru multiple 85 
mechanisms, also involving the chromatin network.  86 
Genome instability is a hallmark of cancer cells. Well-known cancer-associated 87 
factors such as Breast cancer type 1/2 susceptibility proteins (BRCA1/2) have been 88 
demonstrated to impact R-loop homeostasis (1). ATP-dependent chromatin remodelers 89 
are frequently altered in cancer, with the SWItch/Sucrose Non-Fermentable  90 
(SWI/SNF) complex genes accumulating mutation at frequencies close to those of the 91 
Tumor Protein P53 (TP53) gene (2). SWI/SNF’s contribution to transcription had been 92 
extensively studied, but little was known about its impact on genome integrity. Our 93 
recently published work (3) unveils a novel role for SWI/SNF in preventing DNA 94 
replication stress by helping solve transcription-replication conflicts (TRCs), which may 95 
be an important source of DNA damage and genome instability. In particular, SWI/SNF 96 
mutations effect in genome instability was found epistatic to Fanconi Anemia 97 
Complementation Group D2 (FANCD2), a member of the Fanconi Anemia pathway of 98 
repair accumulating at sites of RF stalling, directly linking SWI/SNF to TRC resolution 99 
rather than prevention.  100 
A major contribution of SWI/SNF-related Matrix-associated Actin-dependent 101 
Regulator of Chromatin subfamily A (SMARCA), member 4 (SMARCA4), best known 102 
as Brahma-related gene 1 (BRG1), but not SMARCA member 2 (SMARCA2), also 103 
named Brahma (BRM), the two ATPase subunits of the human SWI/SNF, was shown 104 
to play a central role in TRC resolution. Consistently, BRG1 generally associates with 105 
proliferative tissues with DNA replication rates, whereas BRM is mostly linked to 106 
differentiated tissues with low replication (4,5). SWI/SNF may exist in several complex 107 
subtypes including canonical BRG1-associated factor (cBAF), non-canonical BAF 108 
(ncBAF) and polybromo BRG1-associated factor (PBAF) with subunits specific to each 109 
subtype. Interestingly, a major contribution of cBAF complex subtype to TRC outcome 110 
was evidenced by the observation that AT-Rich Interaction Domain 1A (ARID1A) also 111 
accumulates at TRC and its depletion results in R-loop-dependent DNA damage. 112 
Polybromo 1 (PBRM1), a member of the PBAF complex subtype, also influences R-113 
loop homeostasis, but to a lesser extent. Consistently, ARID1A and PBRM1 114 
inactivation also induces R-loops (6,7). Interestingly, BRG1, ARID1A and PBRM1 are 115 
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among the ATP-chromatin remodeling subunit genes most frequently altered in cancer 116 
(2), suggesting a direct connection between their recurrent mutation in malignant cells 117 
and their function preventing TRC-derived genome instability, and highlighting their 118 
importance as putative tumor suppressors. BRM, which does not impact TRCs, present 119 
much lower mutation rates in transformed cells.  120 
Defining the origin and cause of malignancies is crucial to understand the 121 
disease and to generate new therapeutic approaches. According to the Integrative 122 
Onco Genomics (Intogen) database, BRG1, ARID1A and PBRM1 act as cancer-drivers 123 
in several cancer types (8). In these cases, malignancy could be mediated by a 124 
sustained R-loop-induced genome instability eventually leading to cell transformation. 125 
Nevertheless, this process would imply that pre-malignant and/or malignant cells 126 
develop additional mechanisms to deal with DNA replication stress and genome 127 
instability to proliferate (Figure 1a). Indeed, sustained genome instability prior to 128 
malignant transformation might promote mutations that could increase cell fitness and 129 
malignant cell proliferation in contrast to other cells presenting genome instability. The 130 
same rational would apply when malignancy is acquired, since cancer cells able to deal 131 
with its inherent genome instability would proliferate better. 132 
BRG1 is overexpressed in a wide range of cancers (9). It is possible that under 133 
DNA replication stress higher levels of BRG1 confer a cell proliferation advantage 134 
given its role in TRC resolution and genome integrity (Figure 1b). If so, the use of 135 
BRG1-targeting drugs would be a plausible approach to limit cancer cell proliferation, 136 
by restoring the high genome instability, thus affecting cell fitness. A similar mechanism 137 
has been suggested for Inositol requiring 80 (INO80) complex, which also impacts on 138 
R-loop homeostasis (10). INO80 depletion inhibits cell growth in PC3 (prostate cancer), 139 
MCF7 (breast cancer) and WM1361 (melanoma) cancer cells, but co-depletion of 140 
INO80 and ribonuclease H1 (RNase H1), which degrades the RNA moiety from DNA-141 
RNA hybrids, restores cell proliferation.  142 
Therefore, even though dysfunction of SWI/SNF triggers genome instability and 143 
might promote cell transformation, different survival mechanisms can be used in some 144 
cancer types with high genome instability. Unveiling the contribution of the chromatin-145 
remodeling network is vital to understand how cells proliferate under DNA replication 146 
stress. Identifying the chromatin activities used by SWI/SNF-deficient cancer cells to 147 
grow despite its high R-loop-dependent genome instability could serve to design new 148 
drugs targeting specifically such activities. The combined use of such drugs with DNA 149 
replication stress-inducing drugs could block cell proliferation in malignancies with up-150 
regulated SWI/SNF levels. In support of this possibility, PBRM1 deficiency was found 151 
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to be synthetic lethal with Poly(ADP-Ribose) Polymerase (PARP) and Ataxia 152 
Telangiectasia And Rad3-Related (ATR) inhibitors (7). 153 
In conclusion, identification of the cause-effect relationship of SWI/SNF 154 
alterations in several cancer types could permit designing new strategies to specifically 155 
target malignant cells. The identification of R-loop-mediated replication stress may 156 
suppose a step forward in this direction. 157 
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